欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号UK/H/2388/001
药品名称PEDIACEL
活性成分
    • diphtheria toxoid, adsorbed 30.0 IU
    • filamentous haemagglutinin of bordetella pertussis 20.0 µg
    • fimbrial-2 and -3 antigens of Bordetella pertussis 5.0 µg
    • haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid 10.0 µg
    • inactivated type 1 polio virus, strain Mahoney 40.0 D antigen unit
    • inactivated type 2 polio virus, strain MEF 1 8.0 D antigen unit
    • inactivated type 3 polio virus, strain Saukett 32.0 D antigen unit
    • pertactin 3.0 µg
    • Pertussis toxoid 20.0 µg
    • Tetanus toxoid 40.0 IU
剂型Suspension for injection
上市许可持有人SANOFI PASTEUR MSD LIMITED
参考成员国 - 产品名称United Kingdom (UK)
PL 06745/0128 - 0082
互认成员国 - 产品名称
    许可日期2010/10/30
    最近更新日期2024/05/15
    药物ATC编码
      • J07CA06 diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
    申请类型
    • TypeLevel1:Known Active Substance
    • TypeLevel2:Initial Application
    • TypeLevel3:Full Dossier
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
      市场状态Withdrawn(注:已撤市)
      ©2006-2026 Drugfuture->European Union HMA Authorisation of Medicines DataBase